MEP44608A - Methods for treating infectious disease exacerbated asthma - Google Patents
Methods for treating infectious disease exacerbated asthmaInfo
- Publication number
- MEP44608A MEP44608A MEP-446/08A MEP44608A MEP44608A ME P44608 A MEP44608 A ME P44608A ME P44608 A MEP44608 A ME P44608A ME P44608 A MEP44608 A ME P44608A
- Authority
- ME
- Montenegro
- Prior art keywords
- methods
- infectious disease
- treating infectious
- exacerbated asthma
- disease exacerbated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/17—Immunomodulatory nucleic acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66954805P | 2005-04-08 | 2005-04-08 | |
PCT/US2006/013193 WO2006110607A2 (en) | 2005-04-08 | 2006-04-10 | Methods for treating infectious disease exacerbated asthma |
Publications (1)
Publication Number | Publication Date |
---|---|
MEP44608A true MEP44608A (en) | 2011-02-10 |
Family
ID=36934412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MEP-446/08A MEP44608A (en) | 2005-04-08 | 2006-04-10 | Methods for treating infectious disease exacerbated asthma |
Country Status (19)
Country | Link |
---|---|
US (1) | US20060229271A1 (ja) |
EP (1) | EP1874325A2 (ja) |
JP (1) | JP2008535859A (ja) |
KR (1) | KR20080008350A (ja) |
CN (1) | CN101193646A (ja) |
AU (1) | AU2006235284A1 (ja) |
BG (1) | BG109985A (ja) |
BR (1) | BRPI0610449A2 (ja) |
CA (1) | CA2603976A1 (ja) |
HR (1) | HRP20070516A2 (ja) |
IL (1) | IL186507A0 (ja) |
ME (1) | MEP44608A (ja) |
MX (1) | MX2007012488A (ja) |
NO (1) | NO20075491L (ja) |
RS (1) | RS20070422A (ja) |
RU (1) | RU2007141402A (ja) |
SG (1) | SG161260A1 (ja) |
WO (1) | WO2006110607A2 (ja) |
ZA (1) | ZA200708863B (ja) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7935675B1 (en) | 1994-07-15 | 2011-05-03 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US20030026782A1 (en) * | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6239116B1 (en) | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
AU761899B2 (en) | 1998-05-22 | 2003-06-12 | Ottawa Health Research Institute | Methods and products for inducing mucosal immunity |
US20030022854A1 (en) | 1998-06-25 | 2003-01-30 | Dow Steven W. | Vaccines using nucleic acid-lipid complexes |
JP5084984B2 (ja) | 1999-02-17 | 2012-11-28 | シーエスエル、リミテッド | 免疫原複合体およびそれに関する方法 |
TR200503031T2 (tr) * | 1999-09-25 | 2005-09-21 | University Of Iowa Research Foundation | İmmünostimülatör nükleik asitler |
US6949520B1 (en) | 1999-09-27 | 2005-09-27 | Coley Pharmaceutical Group, Inc. | Methods related to immunostimulatory nucleic acid-induced interferon |
ATE402715T1 (de) * | 1999-11-19 | 2008-08-15 | Csl Ltd | Hcv-impfstoff zusammensetzungen |
PT1446162E (pt) | 2001-08-17 | 2009-01-27 | Coley Pharm Gmbh | Agrupamentos imunoestimuladores oligonucléotidos com actividade melhorada |
NZ573064A (en) | 2002-04-04 | 2011-02-25 | Coley Pharm Gmbh | Immunostimulatory G,U-containing oligoribonucleotides |
US20040053880A1 (en) | 2002-07-03 | 2004-03-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US7807803B2 (en) | 2002-07-03 | 2010-10-05 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
AR040996A1 (es) | 2002-08-19 | 2005-04-27 | Coley Pharm Group Inc | Acidos nucleicos inmunoestimuladores |
EP2241325B1 (en) * | 2002-10-29 | 2012-02-08 | Coley Pharmaceutical Group, Inc. | Use of CPG oligonucleotides in the treatment of hepatitis C virus infection |
US7956043B2 (en) | 2002-12-11 | 2011-06-07 | Coley Pharmaceutical Group, Inc. | 5′ CpG nucleic acids and methods of use |
CA2540949A1 (en) | 2003-10-30 | 2005-05-12 | Coley Pharmaceutical Gmbh | C-class oligonucleotide analogs with enhanced immunostimulatory potency |
MY159370A (en) | 2004-10-20 | 2016-12-30 | Coley Pharm Group Inc | Semi-soft-class immunostimulatory oligonucleotides |
AU2006266503B2 (en) * | 2005-07-01 | 2011-12-08 | Index Pharmaceuticals Ab | Immunostimulatory method |
DE602006008473D1 (de) | 2005-07-01 | 2009-09-24 | Index Pharmaceuticals Ab | Modulierung der reaktion auf steroide |
AU2006306521B2 (en) * | 2005-10-21 | 2011-12-22 | Medical College Of Georgia Research Institute, Inc. | The induction of indoleamine 2,3-dioxygenase in dendritic cells by TLR ligands and uses thereof |
EP1940472A1 (en) | 2005-10-28 | 2008-07-09 | Index Pharmaceuticals AB | Composition and method for the prevention, treatment and/or alleviation of an inflammatory disease |
WO2007062107A2 (en) | 2005-11-25 | 2007-05-31 | Coley Pharmaceutical Gmbh | Immunostimulatory oligoribonucleotides |
CA2642152C (en) * | 2006-02-15 | 2016-11-01 | Coley Pharmaceutical Gmbh | Compositions and methods for oligonucleotide formulations |
NZ575437A (en) | 2006-09-27 | 2012-02-24 | Coley Pharm Gmbh | Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity |
CA2687441A1 (en) * | 2007-05-17 | 2008-11-27 | Coley Pharmaceutical Group, Inc. | Class a oligonucleotides with immunostimulatory potency |
EP2155889A4 (en) * | 2007-05-25 | 2010-06-16 | Centocor Ortho Biotech Inc | TOLL RECEPTOR 3 MODULATORS AND USES THEREOF |
US8552165B2 (en) * | 2008-12-09 | 2013-10-08 | Heather Davis | Immunostimulatory oligonucleotides |
EP2376107B1 (en) * | 2008-12-09 | 2014-05-21 | Coley Pharmaceutical Group, Inc. | Immunostimulatory oligonucleotides |
CA2756412C (en) | 2009-03-25 | 2019-02-26 | The Board Of Regents Of The University Of Texas System | Compositions for stimulation of mammalian innate immune resistance to pathogens |
US10286065B2 (en) | 2014-09-19 | 2019-05-14 | Board Of Regents, The University Of Texas System | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds |
Family Cites Families (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5112605A (en) * | 1989-03-17 | 1992-05-12 | Genentech, Inc. | Temporal gamma-interferon administration for allergies |
US5514788A (en) * | 1993-05-17 | 1996-05-07 | Isis Pharmaceuticals, Inc. | Oligonucleotide modulation of cell adhesion |
US5498410A (en) * | 1991-04-22 | 1996-03-12 | Gleich; Gerald J. | Method for the treatment of eosinophil-associated conditions with anionic polymers |
WO1995026204A1 (en) * | 1994-03-25 | 1995-10-05 | Isis Pharmaceuticals, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
US6727230B1 (en) * | 1994-03-25 | 2004-04-27 | Coley Pharmaceutical Group, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
US7935675B1 (en) * | 1994-07-15 | 2011-05-03 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US20030050263A1 (en) * | 1994-07-15 | 2003-03-13 | The University Of Iowa Research Foundation | Methods and products for treating HIV infection |
DE69535036T3 (de) * | 1994-07-15 | 2011-07-07 | The University of Iowa Research Foundation, IA | Immunomodulatorische oligonukleotide |
US6429199B1 (en) * | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
US20030026782A1 (en) * | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6239116B1 (en) * | 1994-07-15 | 2001-05-29 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
DE69617856T2 (de) * | 1995-04-13 | 2002-06-27 | Milkhaus Laboratory, Inc. | Methoden zur behandlung von atemwegserkrankungen |
US6025339A (en) * | 1995-06-07 | 2000-02-15 | East Carolina University | Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation |
US6040296A (en) * | 1995-06-07 | 2000-03-21 | East Carolina University | Specific antisense oligonucleotide composition & method for treatment of disorders associated with bronchoconstriction and lung inflammation |
US20030078223A1 (en) * | 1996-01-30 | 2003-04-24 | Eyal Raz | Compositions and methods for modulating an immune response |
EP0855184A1 (en) * | 1997-01-23 | 1998-07-29 | Grayson B. Dr. Lipford | Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination |
US20030064945A1 (en) * | 1997-01-31 | 2003-04-03 | Saghir Akhtar | Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors |
AU738513B2 (en) * | 1997-02-28 | 2001-09-20 | University Of Iowa Research Foundation, The | Use of nucleic acids containing unmethylated CpG dinucleotide in the treatment of LPS-associated disorders |
US6406705B1 (en) * | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
AU7690898A (en) * | 1997-05-20 | 1998-12-11 | Ottawa Civic Hospital Loeb Research Institute | Vectors and methods for immunization or therapeutic protocols |
US6589940B1 (en) * | 1997-06-06 | 2003-07-08 | Dynavax Technologies Corporation | Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
WO1999001154A1 (en) * | 1997-07-03 | 1999-01-14 | University Of Iowa Research Foundation | Method for inhibiting immunostimulatory dna associated responses |
PT1009413E (pt) * | 1997-09-05 | 2007-05-31 | Univ California | Utilização de oligonucleótidos imumoestimulantes para a prevenção ou tratamento da asma. |
JPH11209289A (ja) * | 1998-01-22 | 1999-08-03 | Taisho Pharmaceut Co Ltd | 粘膜免疫誘起剤 |
WO1999051259A2 (en) * | 1998-04-03 | 1999-10-14 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
IL139646A0 (en) * | 1998-05-14 | 2002-02-10 | Coley Pharm Group Inc | Methods for regulating hematopoiesis using cpg-oligonucleotides |
AU766492B2 (en) * | 1998-09-18 | 2003-10-16 | Dynavax Technologies Corporation | Methods of treating IgE-associated disorders and compositions for use therein |
US6977245B2 (en) * | 1999-04-12 | 2005-12-20 | The United States Of America As Represented By The Department Of Health And Human Services | Oligodeoxynucleotide and its use to induce an immune response |
US6514948B1 (en) * | 1999-07-02 | 2003-02-04 | The Regents Of The University Of California | Method for enhancing an immune response |
TR200503031T2 (tr) * | 1999-09-25 | 2005-09-21 | University Of Iowa Research Foundation | İmmünostimülatör nükleik asitler |
US7223398B1 (en) * | 1999-11-15 | 2007-05-29 | Dynavax Technologies Corporation | Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
AU2001231245A1 (en) * | 2000-01-31 | 2001-08-07 | The Regents Of The University Of California | Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen |
US7585847B2 (en) * | 2000-02-03 | 2009-09-08 | Coley Pharmaceutical Group, Inc. | Immunostimulatory nucleic acids for the treatment of asthma and allergy |
US20040131628A1 (en) * | 2000-03-08 | 2004-07-08 | Bratzler Robert L. | Nucleic acids for the treatment of disorders associated with microorganisms |
US20020028784A1 (en) * | 2000-03-10 | 2002-03-07 | Nest Gary Van | Methods of preventing and treating viral infections using immunomodulatory polynucleotide sequences |
US20010046967A1 (en) * | 2000-03-10 | 2001-11-29 | Gary Van Nest | Methods of preventing and treating respiratory viral infection using immunomodulatory polynucleotide |
CA2410371C (en) * | 2000-06-22 | 2015-11-17 | University Of Iowa Research Foundation | Methods for enhancing antibody-induced cell lysis and treating cancer |
US20020091097A1 (en) * | 2000-09-07 | 2002-07-11 | Bratzler Robert L. | Nucleic acids for the prevention and treatment of sexually transmitted diseases |
US20030055014A1 (en) * | 2000-12-14 | 2003-03-20 | Bratzler Robert L. | Inhibition of angiogenesis by nucleic acids |
CN1293192C (zh) * | 2000-12-27 | 2007-01-03 | 戴纳瓦克斯技术公司 | 免疫调节性多核苷酸及其使用方法 |
US20030050268A1 (en) * | 2001-03-29 | 2003-03-13 | Krieg Arthur M. | Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases |
US20030139364A1 (en) * | 2001-10-12 | 2003-07-24 | University Of Iowa Research Foundation | Methods and products for enhancing immune responses using imidazoquinoline compounds |
US20040009949A1 (en) * | 2002-06-05 | 2004-01-15 | Coley Pharmaceutical Group, Inc. | Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory CpG nucleic acids |
US7576066B2 (en) * | 2002-07-03 | 2009-08-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US20040053880A1 (en) * | 2002-07-03 | 2004-03-18 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
US7569553B2 (en) * | 2002-07-03 | 2009-08-04 | Coley Pharmaceutical Group, Inc. | Nucleic acid compositions for stimulating immune responses |
AR040996A1 (es) * | 2002-08-19 | 2005-04-27 | Coley Pharm Group Inc | Acidos nucleicos inmunoestimuladores |
EP2241325B1 (en) * | 2002-10-29 | 2012-02-08 | Coley Pharmaceutical Group, Inc. | Use of CPG oligonucleotides in the treatment of hepatitis C virus infection |
NZ541027A (en) * | 2002-12-23 | 2008-04-30 | Dynavax Tech Corp | Immunostimulatory sequence oligonucleotides and methods of using the same |
US20050004144A1 (en) * | 2003-04-14 | 2005-01-06 | Regents Of The University Of California | Combined use of IMPDH inhibitors with toll-like receptor agonists |
KR20060016817A (ko) * | 2003-06-20 | 2006-02-22 | 콜리 파마슈티칼 게엠베하 | 소분자 톨-유사 수용체 (tlr) 길항제 |
AU2004275876B2 (en) * | 2003-09-25 | 2011-03-31 | Coley Pharmaceutical Gmbh | Nucleic acid-lipophilic conjugates |
US20050100983A1 (en) * | 2003-11-06 | 2005-05-12 | Coley Pharmaceutical Gmbh | Cell-free methods for identifying compounds that affect toll-like receptor 9 (TLR9) signaling |
WO2005080567A1 (de) * | 2004-02-20 | 2005-09-01 | Mologen Ag | Substituiertes, nicht-kodierendes nukleinsäuremolekül zur therapeutischen und prophylaktischen immunstimulation in menschen und höheren tieren |
WO2005111057A2 (en) * | 2004-04-02 | 2005-11-24 | Coley Pharmaceutical Group, Inc. | Immunostimulatory nucleic acids for inducing il-10 responses |
US20060005955A1 (en) * | 2004-07-12 | 2006-01-12 | Orr Troy J | Heat exchanger apparatus and methods for controlling the temperature of a high purity, re-circulating liquid |
AU2005333126A1 (en) * | 2004-07-18 | 2006-12-21 | Csl Limited | Methods and compositions for inducing innate immune responses |
MY159370A (en) * | 2004-10-20 | 2016-12-30 | Coley Pharm Group Inc | Semi-soft-class immunostimulatory oligonucleotides |
AU2006216493A1 (en) * | 2005-02-24 | 2006-08-31 | Coley Pharmaceutical Gmbh | Immunostimulatory oligonucleotides |
WO2007062107A2 (en) * | 2005-11-25 | 2007-05-31 | Coley Pharmaceutical Gmbh | Immunostimulatory oligoribonucleotides |
-
2006
- 2006-04-10 RU RU2007141402/14A patent/RU2007141402A/ru not_active Application Discontinuation
- 2006-04-10 ME MEP-446/08A patent/MEP44608A/xx unknown
- 2006-04-10 RS RSP-2007/0422A patent/RS20070422A/sr unknown
- 2006-04-10 ZA ZA200708863A patent/ZA200708863B/xx unknown
- 2006-04-10 JP JP2008505612A patent/JP2008535859A/ja active Pending
- 2006-04-10 US US11/401,093 patent/US20060229271A1/en not_active Abandoned
- 2006-04-10 MX MX2007012488A patent/MX2007012488A/es unknown
- 2006-04-10 CN CNA2006800202524A patent/CN101193646A/zh active Pending
- 2006-04-10 EP EP06749587A patent/EP1874325A2/en not_active Withdrawn
- 2006-04-10 AU AU2006235284A patent/AU2006235284A1/en not_active Abandoned
- 2006-04-10 SG SG201002508-8A patent/SG161260A1/en unknown
- 2006-04-10 BR BRPI0610449-5A patent/BRPI0610449A2/pt not_active IP Right Cessation
- 2006-04-10 KR KR1020077025842A patent/KR20080008350A/ko not_active Application Discontinuation
- 2006-04-10 CA CA002603976A patent/CA2603976A1/en not_active Abandoned
- 2006-04-10 WO PCT/US2006/013193 patent/WO2006110607A2/en active Application Filing
-
2007
- 2007-10-08 IL IL186507A patent/IL186507A0/en unknown
- 2007-10-30 BG BG109985A patent/BG109985A/bg unknown
- 2007-10-30 NO NO20075491A patent/NO20075491L/no not_active Application Discontinuation
- 2007-11-08 HR HR20070516A patent/HRP20070516A2/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2006235284A1 (en) | 2006-10-19 |
RS20070422A (en) | 2009-01-22 |
RU2007141402A (ru) | 2009-05-20 |
WO2006110607A2 (en) | 2006-10-19 |
US20060229271A1 (en) | 2006-10-12 |
NO20075491L (no) | 2008-01-08 |
BRPI0610449A2 (pt) | 2012-01-10 |
WO2006110607A8 (en) | 2007-01-25 |
JP2008535859A (ja) | 2008-09-04 |
MX2007012488A (es) | 2008-03-11 |
IL186507A0 (en) | 2008-03-20 |
HRP20070516A2 (en) | 2008-12-31 |
SG161260A1 (en) | 2010-05-27 |
BG109985A (bg) | 2008-05-30 |
CN101193646A (zh) | 2008-06-04 |
CA2603976A1 (en) | 2006-10-19 |
EP1874325A2 (en) | 2008-01-09 |
KR20080008350A (ko) | 2008-01-23 |
WO2006110607A3 (en) | 2006-11-30 |
ZA200708863B (en) | 2009-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MEP44608A (en) | Methods for treating infectious disease exacerbated asthma | |
BRPI0909334A2 (pt) | processo de produção de álcool microbiano. | |
EA200702643A1 (ru) | Антитела, связывающие tweak | |
EA200702550A1 (ru) | Способ получения эпоксида | |
FR2933884B1 (fr) | Procede de fabrication d'une piece d'aubage. | |
ES2451523T8 (es) | Compuestos de 3-aminopirrolidina N,N-sustituidos útiles como inhibidores de la recaptaci�n de monoaminas | |
CO6241120A2 (es) | (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS. | |
FR2903992B1 (fr) | Composition de scintillateur, article et procede associe. | |
DE602006020716D1 (de) | Kastenloses formverfahren | |
CL2008002371A1 (es) | Composicion que comprende un polimero de hebra simple con un motivo arn inmunoestimulante; metodo que comprende poner en contacto una celula inmune capaz de producir interferon alfa con dicho polimero; y metodos para tratar el asma, una condicion alergica, el cancer y una enfermedad infecciosa. | |
WO2007014318A3 (en) | Zebrafish models of acute myelogenous leukemia | |
CL2007003641A1 (es) | Compuestos derivados de piperidina sustituida con heterociclos condensados, utiles en el tratamiento de infecciones bacterianas. | |
FR2908423B1 (fr) | Procede de fabrication de biere. | |
DE602007002036D1 (de) | Presseschmiedeverfahren | |
NO20091386L (no) | Fenyloksyanilinderivater | |
FR2938947B1 (fr) | Procede de traitement du signal, notamment audionumerique. | |
FR2900722B1 (fr) | Procede de refroidissement par absorption. | |
ITPI20060162A1 (it) | Sorgente sonora omnidirezionale. | |
ITRM20050308A1 (it) | Metodo per incrementare la sopravvivenza di ceppi batterici del genere rhizobium. | |
BRPI0922882A2 (pt) | instalação de transferência de artigos por aspiração, e processo de desinfecção. | |
DE602007008164D1 (de) | Vorform für eine I.S.-Glasformmaschine | |
DE602006018034D1 (de) | Enzymherstellungsverfahren | |
FR2907121B1 (fr) | Nouveaux derives morphiniques | |
FR2891836B1 (fr) | Silices de surface modifiee par des acides phosphoniques. | |
BRPI0918503A2 (pt) | processo de preparação da 1,6:2,3-dianidro-beta-d-manopiranose |